Table 1.
Dataset with the following baseline characteristics were considered.
| Datasets | Sex: Male)%) | Age mean ± SD | Etiology | Stages (Edmonson) | Platform | Application |
|---|---|---|---|---|---|---|
| GSE57957 | 90 | 65±20 | HBV infection | I, II, III, IV | Illumina | DEGs Identification, prognostic model identification |
| GSE39791 | 84 | 57.5 ± 20 | HBV infection | I, II, III, IV | Illumina | DEGs Identification |
| GSE36376 | 83 | 55.9 ± 10 | HBV and HCV | I, II, III, IV | Illumina | DEGs Identification |
| GSE84005 | 86 | 54.5 ± 18 | HBV and HCV | I, II, III | Affymetrix | DEGs Identification |
| GSE12941 | 100 | 65.5 ± 10 | HBV and HCV | I, II, III | Affymetrix | DEGs Identification |
| GSE64041 | 88 | 64 ± 12 | HBV and HCV | I, II, III, IV | Affymetrix | DEGs Identification |
| GSE45267 | 90 | 51 ± 14 | HBV and HCV | I, II, III, IV | Affymetrix | Diagnostic model and prognostic model validation |
| GSE84402 | 30 | 55 ± 11 | HBV and HCV | I, II, III, IV | Affymetrix | DEGs Identification and diagnostic model validation |